Paragon Wealth Strategies’s Novavax NVAX Stock Holding History
Bought
Maintained
Sold
Other funds holding NVAX
Paragon Wealth Strategies's NVAX Position: Q2 2022 in Review
Paragon Wealth Strategies sold out of Novavax (NVAX) in Q2 2022, closing a stake of 5,000 shares — an estimated $368K sold.
Paragon Wealth Strategies first reported a position in NVAX in Q1 2021 and held it in 5 quarters. The position peaked at $1.06M in Q2 2021. 325 funds tracked by Wall St. Rank hold NVAX as of Q2 2022.
- Paragon Wealth Strategies reported no remaining Novavax position as of Q2 2022 after selling out during the quarter.
- Paragon Wealth Strategies sold 5,000 Novavax shares in Q2 2022, an estimated $368K.
- Paragon Wealth Strategies first reported a position in Novavax in Q1 2021 and held it in 5 quarters.
- Paragon Wealth Strategies's Novavax position peaked at $1.06M in Q2 2021.
- 325 funds tracked by Wall St. Rank held Novavax as of Q2 2022.
Based on Paragon Wealth Strategies's 13F filing for Q2 2022, filed 11 Jul 2022.